Nofi Michael

Insider CIK 1705477 · EWTX Chief Financial Officer · SWTX Chief Accounting Officer

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
EWTX Edgewise Therapeutics, Inc	A Award deriv	2026-08-12	2026-08-14	24,375	—	$0	24,375	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2026-08-12	2026-08-14	48,750	—	$0	48,750	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2026-08-12	2026-08-17	48,750	—	$0	48,750	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2026-08-12	2026-08-14	48,750	—	$0	48,750	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2026-08-12	2026-08-14	24,375	—	$0	24,375	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2026-08-12	2026-08-17	48,750	—	$0	48,750	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2025-11-10	2025-11-13	262,500	—	$0	262,500	SEC↗
EWTX Edgewise Therapeutics, Inc	A Award deriv	2025-11-10	2025-11-13	43,750	—	$0	43,750	SEC↗
SWTX SpringWorks Therapeutics,	D To issuer deriv	2025-07-01	2025-07-02	20,246	—	$0	0	SEC↗
SWTX SpringWorks Therapeutics,	D To issuer deriv	2025-07-01	2025-07-02	8,661	—	$0	0	SEC↗
SWTX SpringWorks Therapeutics,	D To issuer deriv	2025-07-01	2025-07-02	65,000	—	$0	0	SEC↗
SWTX SpringWorks Therapeutics,	D To issuer deriv	2025-07-01	2025-07-02	78,300	—	$0	0	SEC↗
SWTX SpringWorks Therapeutics,	D To issuer deriv	2025-07-01	2025-07-02	40,000	—	$0	0	SEC↗
SWTX SpringWorks Therapeutics,	D To issuer	2025-07-01	2025-07-02	30,623	—	$0	0	SEC↗
SWTX SpringWorks Therapeutics,	A Award deriv	2025-01-10	2025-01-14	20,246	—	$0	20,246	SEC↗
SWTX SpringWorks Therapeutics,	A Award	2025-01-10	2025-01-14	6,929	—	$0	30,623	SEC↗
SWTX SpringWorks Therapeutics,	F Tax w/h	2025-01-06	2025-01-07	1,009	$38.86	$39.2K	23,694	SEC↗
SWTX SpringWorks Therapeutics,	F Tax w/h	2025-01-05	2025-01-07	1,636	$38.19	$62.5K	24,703	SEC↗
SWTX SpringWorks Therapeutics,	F Tax w/h	2025-01-04	2025-01-07	2,388	$38.19	$91.2K	26,339	SEC↗
SWTX SpringWorks Therapeutics,	F Tax w/h	2024-01-08	2024-01-08	1,063	$41.53	$44.1K	28,727	SEC↗
SWTX SpringWorks Therapeutics,	F Tax w/h	2024-01-05	2024-01-08	1,169	$37.96	$44.4K	29,790	SEC↗
SWTX SpringWorks Therapeutics,	A Award deriv	2024-01-04	2024-01-08	40,000	—	$0	40,000	SEC↗
SWTX SpringWorks Therapeutics,	A Award	2024-01-04	2024-01-08	14,104	—	$0	30,959	SEC↗
SWTX SpringWorks Therapeutics,	F Tax w/h	2023-01-07	2023-01-10	409	$26.41	$10.8K	16,855	SEC↗
SWTX SpringWorks Therapeutics,	F Tax w/h	2023-01-06	2023-01-09	783	$27.52	$21.5K	17,264	SEC↗
SWTX SpringWorks Therapeutics,	A Award deriv	2023-01-05	2023-01-09	30,000	—	$0	30,000	SEC↗
SWTX SpringWorks Therapeutics,	A Award deriv	2023-01-05	2023-01-09	35,000	—	$0	35,000	SEC↗
SWTX SpringWorks Therapeutics,	A Award	2023-01-05	2023-01-09	9,713	—	$0	18,047	SEC↗
[SWTX SpringWorks Therapeutics,	F Tax w/h	2022-01-07	2022-01-11	567	$56.06	$31.8K	8,181	SEC↗
SWTX SpringWorks Therapeutics,	F Tax w/h	2022-01-07	2022-01-14	414	$56.06	$23.2K	8,334	SEC↗
SWTX SpringWorks Therapeutics,	A Award deriv	2022-01-06	2022-01-10	17,913	—	$0	17,913	SEC↗
SWTX SpringWorks Therapeutics,	A Award	2022-01-06	2022-01-10	5,748	—	$0	8,748	SEC↗
SWTX SpringWorks Therapeutics,	A Award deriv	2021-01-07	2021-01-11	24,000	—	$0	24,000	SEC↗
SWTX SpringWorks Therapeutics,	A Award	2021-01-07	2021-01-11	3,000	—	$0	3,000	SEC↗
SWTX SpringWorks Therapeutics,	A Award deriv	2019-12-02	2019-12-03	78,300	—	$0	78,300	SEC↗